Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: OEIC
  • Objective: European Reg. ex UK
  • Asset Class: Equity
  • Geographic Focus: European Reg. ex UK

F&C Investment Funds ICVC - European Growth & Income Fund

+ Add to Watchlist

RSLEU3I:LN

953.10 GBp 15.50 1.65%

As of 09:53:43 ET on 05/28/2015.

Snapshot for F&C Investment Funds ICVC - European Growth & Income Fund (RSLEU3I)

Year To Date: +11.42% 3-Month: +3.63% 3-Year: +22.59% 52-Week Range: 748.70 - 962.90
1-Month: -0.42% 1-Year: +9.93% 5-Year: +13.23% Beta vs FTWIWXUK: 0.91

Mutual Fund Chart for RSLEU3I

No chart data available.
  • RSLEU3I:LN 953.10
  • 1M
  • 1Y
Interactive RSLEU3I Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RSLEU3I

F&C Investment Funds ICVC - European Growth & Income Fund is an open-end investment company incorporated in the United Kingdom. The Fund aims to achieve medium to long-term growth and income. The Fund invests primarily in European equities.

Inception Date: 10-25-1999 Telephone: 44-870-601-6183
Managers: MARK NICHOLS
Web Site: www.fandc.co.uk

Fundamentals for RSLEU3I

NAV (on 2015-05-28) 953.10
Assets (M) (on 2014-11-20) 352.88
Fund Leveraged N
Minimum Investment 50,000,000.00
Minimum Subsequent Investment 25,000.00

Dividends for RSLEU3I

Dividend Type Accumulation
Dividend Frequency Annual
Last Dividend Net (on 2015-05-01) 19.19
Dividend Yield (ttm) 2.24

Fees & Expenses for RSLEU3I

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.40
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.47

Top Fund Holdings for RSLEU3I

Filing Date: 02/28/2015
Name Position Value % of Total
Novartis AG 329,512 21,912,377 6.112%
Roche Holding AG 87,837 15,513,353 4.327%
Svenska Handelsbanken AB 1,328,388 14,429,791 4.025%
Allianz SE 115,911 12,547,635 3.500%
Reed Elsevier NV 755,303 12,174,044 3.396%
Wolters Kluwer NV 544,528 11,457,303 3.196%
Glanbia PLC 899,649 10,592,656 2.955%
SAP SE 230,434 10,493,130 2.927%
Unilever NV 343,477 9,759,170 2.722%
Bayer AG 101,437 9,716,325 2.710%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil